Case cluster of RT-PCR COVID-19 positive patients with an unexpected benign clinical course with vitamin D, melatonin, vitamin C, and Viscum album
Der Merkurstab 2024;77(1):9-12.
Article-ID: DMS-21733-EN
DOI: https://doi.org/10.14271/DMS-21733-EN
Background: The SARS-CoV-2 global pandemic has been noted to have a differential effect on those exposed depending on risk factors such as age, diabetes, cardiovascular disease and cancer.
Case presentation: We report a case series of 12 confirmed positive patients and 12 presumptive positive patients all of whom had either an entirely asymptomatic or relatively mild clinical course. 2 patients had active cancer, 3 patients were cancer survivors, 1 patient without cancer was 74 years old. All patients were treated early in their disease course with vitamin D loading (50,000 IU daily for 3 days), 60 to 240 mg melatonin, and 2000 mg oral vitamin C. The 6 high risk patients and one 59 year old patient were treated with at least 2 intravenous doses of vitamin C. The 2 patients with active cancer received 75 grams of vitamin C (one daily, the other every other day). All of the high risk patients had a nearly asymptomatic clinical course and were tested after 10 days and all had a RT PCR for COVID-19 that was negative. The 17 remaining patients also had a relatively benign course though 4 patients (2 in their 20s, 2 in their 50s) received this treatment course later in the course of their illness. These were notably the only patients who had more than a mild sore throat or low grade fever.
Conclusion: We report these unexpectedly positive clinical outcomes of COVID-19 patients including patients with different risk factors, under supplemental vitamin C and D and melatonin. These supplements have a favorable safety profile and are already being suggested as potentially disease altering therapies in the COVID-19 pandemic.
1 Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. The Lancet Infectious Diseases 2020;20(5):533–534. DOI: https://doi.org/10.1016/S1473-3099(20)30120-1. [Crossref]
2 Kakodkar P, Kaka N, Baig MN. A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19). Cureus 2020;12(4):e7560. DOI: https://doi.org/10.7759/cureus.7560. [Crossref]
3 Jin X, Lian JS, Hu JH, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 2020;69(6):1002–1009. DOI: https://doi.org/10.1136/gutjnl-2020-320926. [Crossref]
4 Mahase E. Covid-19: Death rate is 0.66% and increases with age, study estimates. BMJ 2020;369. DOI: https://doi.org/10.1136/bmj.m1327. [Crossref]
5 Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China. The European Respiratory Journal 2020;55(5):2000547. DOI: https://doi.org/10.1183/13993003.00547-2020. [Crossref]
6 Ganatra S, Hammond SP, Nohria A. The novel coronavirus disease (COVID-19) threat for patients with cardiovascular disease and cancer. JACC CardioOncology 2020;2(2):350–355. DOI: https://doi.org/10.1016/j.jaccao.2020.03.001. [Crossref]
7 Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncology 2020;21(3):335–337. DOI: https://doi.org/10.1016/S1470-2045(20)30096-6. [Crossref]
8 Gasmi A, Noor S, Tippairote T, et al. Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic. Clinical Immunology 2020;215:108409. DOI: https://doi.org/10.1016/j.clim.2020.108409. [Crossref]
9 Grant WB, Lahore H, McDonnell, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 2020;12(4):988. DOI: https://doi.org/10.3390/nu12040988. [Crossref]
10 Zhang M, Jativa DF. Vitamin C supplementation in the critically ill. Sage Open Medicine 2018;6. DOI: https://doi.org/10.1177/2050312118807615. [Crossref]
11 Carr AC. A new clinical trial to test high-dose vitamin C in patients with COVID-19. Critical Care 2020;24(1):133. DOI: https://doi.org/10.1186/s13054-020-02851-4. [Crossref]
12 Wu GC, Peng CK, Liao WI, et al. Melatonin receptor agonist protects against acute lung injury induced by ventilator through up-regulation of IL-10 production. Respiratory Research 2020;21(1):65. DOI: https://doi.org/10.1186/s12931-020-1325-2. [Crossref]
13 Zhang R, Wang X, Ni L, et al. COVID-19: Melatonin as a potential adjuvant treatment. Life Sciences 2020;250:117583. DOI: https://doi.org/10.1016/j.lfs.2020.117583. [Crossref]
14 Cardinali D, Escames G, Acuña-Castroviejo D, et al. Melatonin-induced oncostasis, mechanisms and clinical relevance. Journal of Integrated Oncology 2016;S1.
15 Evans M, Bryant S, Huntley A, et al. Cancer patients’ experiences of using mistletoe (Viscum album): a qualitative systematic review and synthesis. Journal of Alternative and Complementary Medicine 2016;22(2):134–144. DOI: https://doi.org/10.1089/acm.2015.0194. [Crossref]
16 Saha C, Das M, Stephen-Victor E, et al. Differential effects of Viscum album preparations on the maturation and activation of human dendritic cells and CD4+ t cell responses. Molecules 2016;21(7):912. DOI: https://doi.org/10.3390/molecules21070912. [Crossref]
17 Lavelle EC, Grant G, Pusztai A, et al. Mistletoe lectins enhance immune responses to intranasally co-administered herpes simplex virus glycoprotein D2. Immunology 2002;107(2):268–274. DOI: https://doi.org/10.1046/j.1365-2567.2002.01492.x. [Crossref]
18 Tusenius KJ, Spoek AM, van Hattum J. Exploratory study on the effects of treatment with two mistletoe preparations on chronic hepatitis C. Arzneimittelforschung 2005;55(12):749–753. DOI: https://doi.org/10.1055/s-0031-1296925. [Crossref]
19 Gorter RW, van Wely M, Reif M, et al. Tolerability of an extract of European mistletoe among immunocompromised and healthy individuals. Alternative Therapies in Health and Medicine 1999;5(6):37–44.
20 Collins KP, Jackson KM, Gustafson DL. Hydroxychloroquine: a physiologically-based pharmacokinetic model in the context of cancer-related autophagy modulation. Journal of Pharmacology and Experimental Therapeutics 2018;365(3):447–459. DOI: https://doi.org/10.1124/jpet.117.245639. [Crossref]
21 Xu K, Chen Y, Yuan J, et al. Factors associated with prolonged viral RNA shedding in patients with COVID-19. Clinical Infectious Diseases 2020;ciaa351. DOI: https://doi.org/10.1093/cid/ciaa351. [Crossref]
22 Office of Dietary Supplements. Vitamin C: Fact Sheet for Health Professionals. 2020. Available at https://ods.od.nih.gov/factsheets/VitaminCHealthProfessional (10.05.2023).
23 Adams KK, Baker WL, Sobieraj DM. Myth busters: dietary supplements and COVID-19. Annals of Pharmacotherapy 2020;54(8). DOI: https://doi.org/10.1177/1060028020928052. [Crossref]
24 Anderson G, Reiter RJ. Melatonin: Roles in influenza, Covid- 19, and other viral infections. Reviews in Medical Virology 2020;30(3):e2109. DOI: https://doi.org/10.1002/rmv.2109. [Crossref]
25 Oei SL, Thronicke A, Schad F. Mistletoe and immunomodulation: insights and implications for anticancer therapies. Evidence- Based Complementary and Alternative Medicine 2019. DOI: https://doi.org/10.1155/2019/5893017. [Crossref]
26 Hegde P, Maddur MS, Friboulet A, et al. Viscum album exerts anti-inflammatory effect by selectively inhibiting cytokine- induced expression of cyclooxygenase-2. PLOS ONE 2011;6(10):e26312. DOI: https://doi.org/10.1371/journal.pone.0026312. [Crossref]
27 Steinborn C, Klemd AM, Sanchez-Campillo AS, et al. Viscum album neutralizes tumorinduced immunosuppression in a human in vitro cell model. PLOS ONE 2017;12(7):e0181553. https://doi.org/10.1371/journal.pone.0181553. [Crossref]
